Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 6:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 22,242 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: control 2 Clear all

Conditions: Efficacy of Financial Incentives
Interventions: Voucher-based incentives; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Prevention, Control
Interventions: Mindfulness Program, Active Comparator; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Los Angeles, California • Evanston, Illinois • Nashville, Tennessee

Conditions: Advanced Malignant Neoplasm, Locally Advanced Malignant Neoplasm
Interventions: standard genetic education, Genetic Counseling, Genetic Testing, Internet-Based Intervention, Survey Administration; Other
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older
Enrollment: 601 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Postherpetic Neuralgia, Pain
Interventions: V116517 50-mg tablets, V116517 30-mg tablets, Pregabalin capsules, Placebo; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 28
States / cities: Tucson, Arizona • La Jolla, California • North Hollywood, California + 25 more

Conditions: Fractures, Bone
Interventions: CPM; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Phantom Limb Pain
Interventions: Farabloc Limb Cover, Sham Limb Cover; Device
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Diabetes Mellitus, Type 2
Interventions: Self-Affirmation; Behavioral
Lead sponsor: Elizabeth Scharnetzki; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Westbrook, Maine

Conditions: Low Income Families Basic Social Needs
Interventions: Basic Needs Surveillance (BNS) protocol; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 336 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 9
States / cities: Boston, Massachusetts • Dorchester, Massachusetts • Roslindale, Massachusetts + 2 more

Conditions: Marital Relationships, Family Relations, Low-Income Population, Child Behavior, Adolescent Behavior
Interventions: A Family-Strengthening Program for Low-Income Families; Behavioral
Lead sponsor: MDRC; Other
Eligibility: 18 Years and older
Enrollment: 6,298 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 8
States / cities: Wichita, Kansas • New York, New York • The Bronx, New York + 5 more

Conditions: Relapsing-remitting Multiple Sclerosis
Interventions: Vatelizumab, Placebo (for Vatelizumab); Drug
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 12
States / cities: Cullman, Alabama • Phoenix, Arizona • Fort Collins, Colorado + 9 more

Conditions: Meningitis, Meningococcal
Interventions: rLP2086 vaccine, control; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 10 Years to 25 Years
Enrollment: 5,715 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 39
States / cities: Huntsville, Alabama • Chandler, Arizona • Tempe, Arizona + 28 more

Conditions: Hypoalbuminemia, Protein-energy Malnutrition, Inflammation, Oxidative Stress, Chronic Kidney Disease (CKD) Hemodialysis
Interventions: pentoxiphylline, Nepro, anti-inflammatory module (similar to Oxepa), Placebo pill imitating pentoxiphylline, Placebo to imitate Nepro, Placebo to imitate anti-inflammatory module (similar to Oxepa); Drug · Dietary Supplement
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Irvine, California • Torrance, California

Conditions: Breast Cancer, Cognitive Change, Cognitive Impairment, Quality of Life
Interventions: Sweep Seeker, Bird Safari, Jewel Diver, Master Gardener, Road Tour, Computerized Crossword Puzzles; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Diabetic Neuropathy
Interventions: Placebo, Pulsatile IV insulin delivery (humalog, humulin, novolog); Procedure
Lead sponsor: Florida Atlantic University; Other
Eligibility: 20 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Interstitial Cystitis
Interventions: Pentosan polysulfate sodium 100 mg, Placebo; Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years and older
Enrollment: 369 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 52
States / cities: Birmingham, Alabama • Homewood, Alabama • Anchorage, Alaska + 49 more

Conditions: Depression, Depression, Anxiety, Inflammation
Interventions: Freeze Dried Blueberry Powder - 71717, USHBC Blueberry Placebo Formula #114; Dietary Supplement
Lead sponsor: Louisiana State University, Baton Rouge; Other
Eligibility: 18 Years to 70 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Cottonport, Louisiana • Marksville, Louisiana

Conditions: Complicated Intra-abdominal Infections
Interventions: Ceftazidime -avibactam, Meropenem, Metronidazole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 3 Months to 17 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 4
States / cities: Orange, California • San Diego, California • Toledo, Ohio + 1 more

Conditions: Pain, Ankle Injuries
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Traumatic Brain Injury
Interventions: BETTER (Brain Injury, Education, Training, and Therapy to Enhance Recovery), Usual Care; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Crohn Disease
Interventions: Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 77
States / cities: Dothan, Alabama • Chandler, Arizona • Scottsdale, Arizona + 65 more

Conditions: Autism, Severe Behavior Disorder
Interventions: placebo, glutathione, glutathione, vit C and NAC; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 5 Years to 16 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Adolescent Obesity, Eating Behavior, Dietary Intake
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 14 Years to 19 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 5
States / cities: Birmingham, Alabama • Cincinnati, Ohio • Philadelphia, Pennsylvania + 2 more

Conditions: Necrotizing Enterocolitis
Interventions: ST266; Biological
Lead sponsor: Noveome Biotherapeutics, formerly Stemnion; Industry
Eligibility: 2 Weeks to 8 Weeks
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 8
States / cities: Little Rock, Arkansas • New Haven, Connecticut • Tampa, Florida + 4 more

Conditions: Insulin Resistance, Impaired Glucose Tolerance, Obesity, Metabolic Disturbance
Interventions: Low Physical Activity and Added Carbohydrate Group, Low physical Activity Control, High Physical Activity and Added Carbohydrate Group; Behavioral
Lead sponsor: University of New Hampshire; Other
Eligibility: 18 Years to 30 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Durham, New Hampshire

Search by objective public record fields.

Voucher Based Incentives to Treat Pregnant Smokers

A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures

Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees

Strategies to Improve Well-Being and Diabetes Management

Addressing Low-Income Families' Basic Social Needs at Pediatric Visits

The Supporting Healthy Marriage Evaluation

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

Computerized Cognitive Training in Breast Cancer Survivors

Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis

Effect of Whole Blueberry Powder Consumption on Depression in a Central Louisiana Population

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

Associated Joint Pain With Controlled Ankle Movement (CAM) Walker Boot Wear

BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

Dietary Intake and Eating Behaviors in Adolescents Who Undergo Bariatric Surgery

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults